Skip to main content
. 2019 Apr 30;20(9):2149. doi: 10.3390/ijms20092149

Figure 1.

Figure 1

(A) Analysis of cellular viability with MTT survival experiment in human A673 ES cells after 24 h of treatment with apigenin (10-20-50 μM); (B) Percentage of live cells after ViobilityTM Fixable Dyes assay after 24 h of treatment with apigenin (10-20-50 μM); (C) The apoptotic effect of apigenin analysed after 24 h of treatment (10-20-50 μM); (D) Western Blot analysis of PARP1 enzyme after treatment with apigenin (10-20-50 μM) with β-actin as loading control; (E) Percentage of live cells after ViobilityTM Fixable Dyes assay and apoptotic effect on healthy lymphocytes after 24 h of treatment with apigenin (10-20-50 μM). Apig: apigenin, ns: not significant. p values for treatments: * p < 0.05, ** p < 0.01 and *** p < 0.001.